US Market News
2月前
Altria Holds 2026 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $1.06 Per ShareMay 14, 2026 2:30 PM
Business Wire Altria Group, Inc. (Altria) (NYSE: MO) held our 2026 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria’s Chief Executive Officer (CEO), addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Appointment of CEO Following today’s Annual Meeting, Sal Mancuso succeeded Billy Gifford as Altria’s CEO. At the end of 2025, Billy Gifford announced his decision to retire after more than 30 years of distinguished service with the Altria family of companies. “Sal is immensely qualified to lead Altria, having served in numerous leadership positions during his more than 30-year career with us, including as Chief Financial Officer,” said Billy Gifford. “Altria has a bright future under his leadership.” Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2026 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026; and approved, on an advisory basis, the compensation of our named executive officers. Final voting results will be reported in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission. Regular Quarterly Dividend Following the Annual Meeting, our Board declared a regular quarterly dividend of $1.06 per share, payable on July 10, 2026, to shareholders of record as of June 15, 2026. The ex-dividend date is June 15, 2026. Future dividend payments remain subject to the discretion of our Board. Altria’s Profile We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment. Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA). Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products. Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company. The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission. Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20260513974946/en/ Altria Client Services
Investor Relations
(804) 484-8222 Altria Client Services
Media Relations
www.altria.com/contact-us/media Original: Altria Holds 2026 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $1.06 Per Share
US Market News
2月前
Altria Celebrates America by Investing in Our Growers, Communities, Employees and Iconic BrandsApril 27, 2026 3:15 PM
Business Wire
Altria Group, Inc. (Altria) (NYSE:MO) – Altria’s companies have strong American roots and relationships with farmers that date back more than 200 years. We have a long history of investing in high-quality U.S. jobs and manufacturing, supporting thriving communities and delivering billions of dollars in annual economic value. Today, we are building on that tradition, celebrating America’s 250th birthday with incremental investments in American tobacco growers, our communities, our employees and our iconic brands.
“In a time when many feel divided, America’s 250th birthday is a moment to come together and truly show up for one another in the communities we call home,” said Jennifer Hunter, Senior Vice President of Corporate Citizenship and Chief Sustainability Officer, Altria Client Services. “Altria and its family of companies have a long tradition of giving back to our communities. Together, we’re honoring this milestone by supporting American tobacco growers and creating new ways to serve the communities where we live and work.”
Over the next three years, ALCS, with funding from Philip Morris USA, will provide more than $8 million in philanthropic support to strengthen agricultural education, invest in tobacco-growing communities and continue to engage employees nationwide through service and civic participation. We plan to:
Establish endowments at the University of Kentucky Martin-Gatton College of Agriculture, Food and Environment (CAFE) and the Virginia Tech College of Agriculture and Life Sciences.
Provide donor-advised funds in tobacco-growing regions to support local community needs and future disaster-relief efforts.
Engage nearly 6,000 employees nationwide through volunteerism, charitable giving, and civic learning—creating shared stories of meaningful community impact.
About the University of Kentucky and Virginia Tech Endowments
Altria has built a strong relationship with both the University of Kentucky and Virginia Tech over the last several decades. Each university will receive a total of $2 million across the next three years to support endowed faculty chair positions to strengthen academic and extension capacity in these tobacco-growing communities.
“PM USA has a long history of working with growers and universities to support the long-term sustainability and vibrancy of tobacco farming,” said Jon Moore, President and CEO of PM USA. “These investments complement PM USA’s ongoing commercial purchases of U.S.-grown tobacco and our long-standing business relationships with American tobacco farmers. We know these universities play a vital role in advancing agriculture in the region, and as an American company based in Virginia, this is personal to us.”
“As new uses are established and tobacco markets shift, this generous gift will allow the college to continue to focus on emerging areas of innovation,” said Laura Stephenson, Vice President for Land-grant Engagement and dean of Martin-Gatton CAFE. “Tobacco is still an important part of Kentucky’s agricultural economy. Continuing to serve our growers, students and industry through research and education will help us address evolving challenges and strengthen the long-term sustainability of tobacco production.”
Our investment continues a decades-long relationship with Martin-Gatton CAFE and reflects our sustained commitment to supporting growers, research and agricultural leadership. Over the years, Altria and our subsidiaries, including PM USA, have funded burley and dark-fire tobacco research and Extension programs. Growing experts and advocates are equally important, and we’ve continued to make significant contributions to UK scholarships, graduate fellowships, faculty research support and the Kentucky Agricultural Leadership Program.
“Tobacco has played a defining role in Kentucky’s agricultural heritage for generations,” said Commissioner Jonathan Shell at the Kentucky Department of Agriculture. “While the industry continues to evolve, thousands of Kentucky farmers still rely on tobacco as an important part of their operations. This investment will help ensure we remain at the forefront of innovation, supporting growers with the research and tools they need to stay competitive and sustainable. I encourage others across the industry to join in supporting these efforts to secure a strong future for tobacco in Kentucky.”
We have a long-standing relationship with Virginia Tech, supporting research and Extension efforts within the College of Agriculture and Life Sciences that directly benefit producers. This endowment will provide long-term support for tobacco agronomy at the Southern Piedmont Agricultural Research and Extension Center (AREC), sustaining research, field trials and grower engagement across the Commonwealth of Virginia.
“This investment helps ensure Virginia Tech can continue delivering the research and Extension support that tobacco producers rely on every growing season,” said Mario Ferruzzi, dean of the College of Agriculture and Life Sciences. “By establishing long-term support for tobacco agronomy, we are strengthening our ability to serve the industry today while preparing the next generation of agricultural leaders.”
“Everything we do is focused on helping growers make better decisions in real time,” said David Reed, tobacco agronomist at Virginia Tech’s Southern Piedmont AREC. “This kind of support allows us to stay in the field, work directly with producers, and keep improving the systems they depend on.”
Investing in the Community
We are working to establish new donor-advised funds totaling $4.1 million to support local community needs and future disaster-relief efforts in PM USA’s key tobacco-growing communities in Virginia, North Carolina and Kentucky.
“We know firsthand the challenges that farmers, as well as entire farm communities face,” said Michael Manson, Vice President of Brand Management, PM USA. “Tragic natural disasters have hit the regions during recent years – including tornadoes and flooding that have destroyed family farms and entire communities. In addition to supporting local community needs, this fund can assist in supporting those impacted by future natural disasters.”
Altria’s 2026 Volunteer and Employee Contributions
To keep America’s 250th birthday celebration going, throughout the year we will engage our nearly 6,000 employees around what connects us most: service to others. Through an enterprise program that builds momentum from National Volunteer Month in April, we are creating multiple ways for employees across the country to participate in meaningful, local action that strengthens the places where we live and work. Altria aims to reach 25,000 volunteer hours annually by 2030.
The initiative will expand opportunities for employees to volunteer, donate and learn through accessible challenges and campaigns powered by the Altria Contributing Together platform. Employees will be encouraged to support causes they care about by participating in group volunteering, completing a civic learning challenge and donating funds through an enhanced matching gifts campaign. We will also celebrate in partnership with many of our national and local nonprofit and community partners.
Altria’s Profile
We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.
Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.
Source: Altria Group, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427960042/en/
Altria Client Services
Investor Relations
804-484-8222
Altria Client Services
Media Relations
www.altria.com/contact-us/media
Original: Altria Celebrates America by Investing in Our Growers, Communities, Employees and Iconic Brands
US Market News
3月前
on! PLUS™ Expands Nationwide Retail AvailabilityMarch 23, 2026 3:30 PM
Business Wire
Altria Group, Inc. (Altria) (NYSE: MO) today announced the national retail expansion of on! PLUS™ nicotine pouches, a next-generation oral nicotine pouch product manufactured by Helix Innovations LLC (Helix), an Altria operating company.
“The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria’s Vision of Moving Beyond Smoking®. As adult consumers continue to seek smoke-free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science-based regulatory frameworks,” said Nick MacPhee, Managing Director, Helix.
on! PLUS is the first product authorized through the U.S. Food and Drug Administration’s pilot program designed to expedite the review of nicotine pouch product premarket tobacco product applications. on! PLUS, available in three flavors and two nicotine strengths, features our proprietary NICOSLIK technology and a built-in compartment for responsible disposal.
Building on its availability through e-commerce and at participating retailers in North Carolina, Florida, and Texas, on! PLUS began wholesale deliveries on March 16, 2026. It is expected to reach participating retailers nationwide beginning March 23, 2026.
FDA-authorized on! PLUS products
The FDA authorized the marketing of the following on! PLUS nicotine pouch products:
on! PLUS Mint, 6 mg
on! PLUS Mint, 9 mg
on! PLUS Tobacco, 6 mg
on! PLUS Tobacco, 9 mg
on! PLUS Wintergreen, 6 mg
on! PLUS Wintergreen, 9 mg
Altria’s Profile
We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.
Forward-Looking and Cautionary Statements
This release contains certain forward-looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the availability of our operating companies’ products at retail, and we cannot guarantee any outcomes. Factors that might cause actual results to differ materially from those contained in the forward-looking statements included in this press release include delays with respect to product deliveries, among others. Other risk factors are detailed from time to time in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2025. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this release.
Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260323694075/en/
Investor Relations
Altria Client Services
(804) 484-8222
Media Relations
Altria Client Services
(804) 484-8897
www.altria.com/contact-us/media
Original: on! PLUS™ Expands Nationwide Retail Availability
US Market News
5月前
Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings GuidanceFebruary 18, 2026 7:00 AM
Business Wire
Altria Group, Inc. (Altria) (NYSE: MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Altria’s Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations.
Remarks and Presentation
The presentation will be webcast live on www.altria.com in a listen-only mode, beginning at approximately 1:00 p.m. Eastern Time. A copy of the business presentation, prepared remarks and a replay of the webcast will be available at www.altria.com.
2026 Full-Year Guidance
We reaffirm our guidance to deliver 2026 full-year adjusted diluted earnings per share (EPS) in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025. We expect 2026 adjusted diluted EPS growth to be weighted to the second half of the year, reflecting a progressive increase in cigarette import and export activity over the course of the year.
Our guidance contemplates:
(i) planned investments to support our contract manufacturing capabilities;
(ii) limited impact on combustible and e-vapor product volumes from illicit enforcement efforts; and
(iii) that NJOY ACE does not return to the marketplace in 2026.
Our 2026 full-year adjusted diluted EPS guidance range includes planned investments in support of our Vision, including cost savings generated from our Optimize & Accelerate initiative (Initiative), such as (i) marketplace activities in support of our smoke-free products and (ii) continued smoke-free product research, development and regulatory preparation expenses.
Our full-year adjusted diluted EPS guidance range excludes the impact of certain income and expense items that our management believes are not part of underlying operations. These items may include, for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition, disposition and integration-related items, equity investment-related special items, certain income tax items, charges associated with tobacco and health and certain other litigation items, resolutions of certain non-participating manufacturer (NPM) adjustment disputes under the Master Settlement Agreement (NPM Adjustment Items) and amortization expense associated with definite-lived intangible assets. See Schedule 1 below for the income and expense items for the full-year 2025.
Our management cannot estimate on a forward-looking basis the impact of certain income and expense items, including those items noted in the preceding paragraph, on our reported diluted EPS because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable. As a result, we do not provide a corresponding U.S. generally accepted accounting principles (GAAP) measure for, or reconciliation to, our adjusted diluted EPS guidance.
Altria’s Profile
We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking®, by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.
Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.
Forward-Looking and Cautionary Statements
This release contains projections of future results and other forward-looking statements that are subject to a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.
Important factors that could cause actual results to differ materially from those contained in the forward-looking statements included in this release are described in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. These factors and risks include the following:
our inability to anticipate and respond to changes in ANC preferences and purchase behavior;
our inability to compete effectively;
the growth of the e-vapor category, including illicit disposable e-vapor products, which contributes to reductions in domestic cigarette consumption levels and shipment volume;
the impact of illicit trade in nicotine products and the sale of products designed to avoid the regulatory framework for nicotine products, each of which contribute to reductions in the consumption levels and shipment volumes of our businesses’ products;
our failure to develop and commercialize innovative products, including nicotine products that may reduce health risks relative to other nicotine products and appeal to ANCs;
changes, including in macroeconomic and geopolitical conditions (including inflation and tariffs), that result in shifts in ANC disposable income and purchasing behavior, including choosing lower-priced and discount brands or products, and reductions in shipment volumes;
unfavorable outcomes with respect to litigation proceedings or any governmental investigations, including significant monetary and non-monetary remedies and importation bans;
the risks associated with significant federal, state and local government actions, including FDA regulatory actions and inaction, and various private sector actions;
the risk that regulators, including the FDA, and courts may interpret laws, rules and regulations applicable to our operating companies’ products differently than we do;
increases in nicotine product-related taxes;
our failure to complete or manage successfully strategic relationships or transactions, including acquisitions, dispositions, joint ventures, commercial relationships and investments in third parties, or realize the anticipated benefits of such transactions;
significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of changes in macroeconomic, climate and geopolitical conditions;
our reliance on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers and the risks associated with an extended disruption at a facility or in service by a supplier, distributor or distribution chain service provider;
the risk that we may be required to write down goodwill and intangible assets, including trademarks and other intellectual property, due to impairment;
the risks associated with our Initiative, including risks relating to business continuity, our internal control over financial reporting and audit procedures and our ability to recognize the expected efficiencies;
the risk that we could decide, or be required, to recall products;
the various risks related to health epidemics and pandemics and the measures that international, federal, state and local governments, agencies, law enforcement and health authorities implement to address them;
our inability to attract and retain a highly skilled workforce due to the decreasing social acceptance of tobacco usage, tobacco control actions and other factors;
the risks associated with the various U.S. and foreign laws and regulations to which we are subject due to our international business operations;
the risks concerning a challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws;
the risks associated with legal and regulatory requirements related to climate change and other environmental sustainability matters;
disruption and uncertainty in the credit and capital markets, including risk of losing access to these markets;
a downgrade or potential downgrade of our credit ratings;
the impact of heightened focus by investors and other stakeholders on our performance relating to corporate responsibility matters;
the failure of our, or our key service providers’ or key suppliers’, information systems to function as intended, or cyber-attacks or security breaches affecting us or our key service providers or key suppliers;
our failure, or the failure of our key service providers or key suppliers, to comply with laws related to personal data protection, privacy, artificial intelligence and information security;
the risk that the expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all; and
the risks associated with our investment in Cronos, including legal, regulatory and reputational risks and the risk that the expected benefits of the transaction may not materialize in the expected manner or timeframe or at all.
You should understand that it is not possible to predict or identify all factors and risks. Consequently, you should not consider the foregoing list to be complete. We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Altria or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.
Schedule 1
ALTRIA GROUP, INC.
and Subsidiaries
Reconciliation of GAAP and non-GAAP Measures
(dollars in millions, except per share data)
(Unaudited)
Earnings
before
Income Taxes
Provision
for
Income
Taxes
Net
Earnings
Diluted
EPS
2025 Reported
$
9,389
$
2,442
$
6,947
$
4.12
NPM Adjustment Items
(20
)
(5
)
(15
)
(0.01
)
Acquisition and disposition-related items
76
10
66
0.04
Asset impairment, exit and implementation costs
2,184
263
1,921
1.14
Tobacco and health and certain other litigation items
58
14
44
0.03
Amortization of intangibles
132
22
110
0.06
ABI-related special items
95
20
75
0.04
Cronos-related special items
(5
)
—
(5
)
—
Income tax items
—
(5
)
5
—
2025 Adjusted for Special Items
$
11,909
$
2,761
$
9,148
$
5.42
While we report our financial results in accordance with GAAP, our management reviews certain financial results, including diluted EPS, on an adjusted basis, which excludes certain income and expense items, including those items noted under “2026 Full-Year Guidance” in the release. Our management does not view any of these special items to be part of our underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Our management believes that adjusted financial measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of year-over-year results. Our management uses adjusted financial measures for planning, forecasting and evaluating business and financial performance, including allocating capital and other resources and evaluating results relative to employee compensation targets. These adjusted financial measures are not required by, or calculated in accordance with GAAP, and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260217437353/en/
Altria Client Services
Investor Relations
804-484-8222
Altria Client Services
Media Relations
804-484-8897
www.altria.com/contact-us/media
Original: Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance
iHub News
5月前
Altria posts steady Q4 profit, sets out 2026 outlookJanuary 29, 2026 10:03 AM
IH Market News
Altria Group (NYSE:MO) reported fourth-quarter adjusted earnings that were unchanged from a year earlier, coming in at $1.30 per share and just below analysts’ expectations of $1.32. Revenue net of excise taxes slipped 0.5% to $5.08 billion, but still came in ahead of the $5.02 billion consensus forecast.Shares of the tobacco group eased 0.21% after the results, which again highlighted ongoing pressure on cigarette volumes. In the fourth quarter, Altria’s smokeable products segment saw domestic cigarette shipment volumes fall 7.9%, largely reflecting broader industry declines and trade inventory movements. Adjusting for these factors, the company estimated total U.S. cigarette industry volumes declined by roughly 6.5%.“2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders,” said Billy Gifford, Altria’s Chief Executive Officer. “For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined.”For full-year 2025, Altria reported adjusted diluted EPS of $5.42, up 4.4% from the prior year, while net revenues declined 3.1% to $23.3 billion.Marlboro’s share of the total U.S. cigarette retail market slipped to 39.8% in the fourth quarter, down 1.5 percentage points year on year, as lower-priced brands continued to gain traction amid sustained pressure on discretionary spending among adult nicotine consumers.Within oral tobacco, Altria said its on! nicotine pouches accounted for a 7.7% share of the total U.S. oral tobacco category in the quarter, representing a 1.0 percentage point decline compared with a year earlier.Looking to 2026, Altria guided for full-year adjusted diluted EPS of between $5.56 and $5.72, implying growth of 2.5% to 5.5% versus 2025. The company noted that it expects earnings growth to be skewed toward the second half of the year.Altria Group stock price
Original: Altria posts steady Q4 profit, sets out 2026 outlook
DiscoverGold
2年前
A Blue Chip Stock With a 9.5% Yield
By: 24/7 Wall St. | January 16, 2024
Yield stocks don’t grab many headlines during a period when the value of the Magnificent Seven (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla) have much more than doubled in the past year, compared to a 20% rise in the S&P 500. Why invest in any shares that might underperform the S&P 500 in 2024? (Apple’s stock is actually down in 2024, and tech share prices are shaky in general.) The answer is safety, stability and a yield much better than anything short of junk bonds.
Altria Group Inc. (NYSE: MO), the huge tobacco company, has a dividend yield of 9.4%. Altria stock generally does not move much, either up or down. However, it is lower by 7% compared to the start of the year. (These are the seven highest-yielding 2024 Dividend Kings to buy and hold forever.)
Altria’s revenue fell 4% year over year to $6.3 billion in the most recent quarter. Net income was up sharply from $224 million to $2.2 billion. The 35% net income margin shows the leverage Altria has in making commodity products on which it can get a strong brand price. Almost all its cigarette sales are under the Marlboro brand, which, according to BrandZ, is the 30th most valuable brand in the world at $57 billion. Altria’s chief executive officer, Billy Gifford, commented about the most recent financial results: “Our highly profitable traditional tobacco businesses were resilient in a dynamic operating environment during the third quarter and first nine months, providing fuel for our business transformation and significant cash returns to our shareholders.”
Part of Altria’s magic for yield investors is the $11 billion it has on its balance sheet. Altria does not need this money for operations because of positive cash flow. That means the dividend is solid. The tobacco business may be out of favor, and massive shareholder lawsuits in 1998 that cost the industry $246 billion. Yet, the financial effects of that are long gone as a factor in Altria’s dividend.
Altria’s pitch to investors who are reluctant to invest in a company that makes a deadly product is that it is creating less deadly tobacco products. That is how it describes itself to Wall Street. It is what management calls “Moving Beyond Smoking,” which makes it a “tobacco harm reduction company.” This means producing “smoke-free” tobacco products. Nevertheless, cigarettes drive Altria’s financials and will for many years.
Altria stock investors who are willing to ignore the ill effects of smoking get a tremendous and steady yield.
Read Full Story »»»
DiscoverGold
DiscoverGold
3年前
Altria Group sees insider buying amid concerns over growth consistency
By: Investing | November 12, 2023
An analysis of Altria Group , Inc. (NYSE:MO) has highlighted a blend of optimism and caution among investors and analysts. The company, known for its significant institutional ownership, with 60% of its shares held by institutions, has recently witnessed insider buying that suggests a positive outlook on its future performance.
The top 25 shareholders, including prominent names such as The Vanguard Group, Inc., Capital Research and Management Company, and BlackRock (NYSE:BLK), Inc., collectively control 42% of Altria Group. Despite this substantial institutional presence, there is no single dominant shareholder exerting control over the company.
On the insider front, ownership may be less than 1%, but recent activities show board members are collectively investing in the company's potential, owning about $49 million in shares. This insider buying is often interpreted as confidence in the company's strategic direction and future earnings prospects.
Additionally, the general public maintains a significant interest in Altria Group, holding 40% of the company's shares. This diverse shareholder base contributes to a robust market for the company's stock.
However, analysts are paying close attention to risks associated with 'crowded trades.' This concern arises when multiple institutions own large portions of a company's stock. If sentiment shifts negatively, these institutions may attempt to exit their positions quickly, leading to a rapid sell-off that can negatively impact the stock price. For Altria Group, with its lack of a history of consistent growth, this risk is particularly noteworthy.
The company's future is being closely watched by analysts who provide coverage and forecasts that are vital for investors to gauge Altria Group's prospects. Nonetheless, investors have been cautioned about one specific warning sign related to Altria Group. While details of this risk were not disclosed, it underscores the importance of due diligence and consideration of potential pitfalls when making investment decisions in the company.
In summary, while insider buying at Altria Group may indicate a positive sentiment from those closest to the company's operations, investors are advised to weigh this against the broader context of the company's performance history and potential risks highlighted by analysts.
Read Full Story »»»
DiscoverGold
DiscoverGold
3年前
Altria’s Option Activity Wednesday Was Smokin’: Time to Buy?
By: Barchart | September 15, 2023
How busy was Altria’s (MO) options trading on Wednesday? It had no less than 11 puts or calls exhibiting unusual options activity -- a Vol/OI ratio of 1.25x or higher -- with volumes of 10,000 or more on five of them.
Something is up. It’s been two years since Altria experienced volume like yesterday’s. I’m guessing big hitters picked up long-duration calls, given that the put/call ratio was 0.02.
But as I’ve said, I’m a neophyte regarding options. My skill lies in assessing a company’s strengths and weaknesses vis-a-vis its business model. Good business models -- think Costco (COST) -- never go out of style.
Yesterday’s volume doesn’t confirm that investors are building positions in Altria. However, with volume of just 18,099 at midday on Thursday, I wouldn’t discount it.
So, I’ll answer two questions for readers: First, is Altria a long-term buy? Secondly, which of the 11 unusually active options from Wednesday were worth buying to secure Altria stock in the future?
Yay, Or Nay To Altria?
Everyone and their dog knows about Altria’s humongous dividend yield. With the October 2023 payment of $0.98, up four cents from July, it will have an annualized rate of $3.92, yielding 8.9%. It has increased its dividend for the 58th time over the past 54 years, putting it in an elite company. It is one of only 49 S&P 500 stocks that have increased their annual dividend payout for 50 or more consecutive years.
Also keen about share repurchases, Altria’s shareholder yield -- dividend yield plus buyback yield -- is 10.4%, putting it ahead of most companies in the index.
So, even with interest rates as high as they are, it’s an enticing yield. If you have no problem owning so-called sin stocks like Altria, you’d be silly not to consider MO, which pays you to wait for its share price to appreciate.
For example, although MO stock over the past five years is down more than 29%, its annualized total return is flat, thanks to its consistent dividends, at -0.05%. Over 15 years, it’s 9.3%. Anything over 8% is good in my books.
Earlier this year, Altria announced that it was getting back into the e-cigarette game, buying NJOY Holdings for $2.75 billion, plus $500 million in potential earnouts for achieving certain regulatory approvals. The acquisition is part of the company’s Moving Beyond Smoking business strategy.
“We are excited to add NJOY’s e-vapor intellectual property as a new platform that we believe we can build on to help more adult smokers transition to smoke-free alternatives,” Olivier Houpert, Altria’s Chief Innovation and Product Officer, said in the company’s March press release announcing the deal.
The company has four product segments in its smoke-free offerings: Smokeless Tobacco, often called chewing tobacco, Nicotine Pouches, E-Vapor (NJOY acquisition), and Heated Tobacco products through its majority-owned joint venture with JT Group, the owners of Japan Tobacco.
The e-vapor category generated $7 billion in U.S. retail sales in the past year. It is the largest smoke-free category in the U.S. Altria has an opportunity to capture a big chunk of that.
Altria’s goal for its smoke-free products is $5 billion by 2028. It finished 2022 with $2.6 billion. The acquisition of NJOY should help it meet its goal.
I don’t think there’s any question; Altria is a controversial stock, given its history in the cigarette business. However, the appreciation potential of its smoke-free products combined with the cash flow from its smokable products makes it an excellent contrarian play.
I say yay to MO stock.
The Best Option To Play MO
Over the past five years, MO stock has only traded below $40 on one occasion from March to November 2020. That would make a perfect entry point for buying Altria stock.
Of the 11 unusually active options from yesterday, none will get you all the way there. However, two stand out for me. One is a put -- the only put, by the way -- and the other a call.
The put has a $47.50 strike price with a June 21/2024 expiry, 281 days from now. As of yesterday’s close of $44.75, it was $2.75 in the money. With a $5.25 bid, your net price paid should you have to buy the shares would be $42.25, $1.69 below where it’s currently trading.
With 281 days to expiration, anything could happen. More than likely, it moves above the strike, and you’re left with the premium income yielding 15.2% on an annualized basis. That’s not a bad consolation prize.
As for the call, I like the Jan. 17/2025 $35 strike with a $9.85 ask. Sure, you’re paying 28% of the strike price to secure your right to buy 100 shares of MO stock in 492 days. But at a net price of $44.85, you could be sitting on a decent entry point should Altria shares catch fire over the next 70 weeks.
The volume yesterday on that call was 34,834 or 12.85x its open interest. Anything over 10x suggests there’s some unusual interest.
Both the put and call have long durations that provide sufficient time for the Altria Moving Beyond Smoking business strategy to gain traction with investors.
Read Full Story »»»
DiscoverGold
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Nikodemos
9月前
believeinsteven
11月前
Monksdream
1年前
Bountiful_Harvest
2年前
Lime Time
2年前
メールアドレスで登録
